Amgen Czech Republic - Net Profit Growth

Amgen CR`s Net Profit Growth reached 20.0 % in 2017. This is 265 % less than in the previous year.

$1.99

Buy Net Profit Growth data for Amgen Czech Republic.

$19.99

Buy all data for Amgen Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

Company Unit 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic ... ... ... ... ...           57.1 -38.7 1.42 40.8 -11.4    
Bayer Czech Republic ... ... ...               39.4 -49.7 15.3 11.2 15.4    
GlaxoSmithKline Czech Republic ... ... ...               45.3 -31.8 -22.2 -31.2 42.1    
Merck Czech Republic ... ...                 321 28.7 -56.9 27.5 96.7    
Novartis Czech Republic                     0.860 19.7 4.60 57.3 0.548    
Pfizer Czech Republic ... ...                 137 -79.2 200 -7.25 -43.7    
Roche Czech Republic ... ... ...               -50.1 -23.3 248 -29.6 -46.3   ...
Sanofi-Aventis Czech Republic ... ... ... ...             18.2 -17.9 44.2 -98.2 4,839    
Servier Czech Republic ... ... ... ... ... ... ... ... ... ... ... ... 5.92 0.125 16.7    
Walmark ... ... ...               63.4 -101 187 -585 -1,813